Verified Skilled Worker sponsor
Research GP
Shore Medical PCN
Home Office register entry: Shore Medical, Poole
Visa sponsorship
This role is listed by an employer that holds a live Home Office sponsor licence on the Skilled Worker route.
NHS roles fall under the Health and Care Worker route. Public reference figures for that route: the general salary minimum is £25,000 a year, and salaries set by national pay scales (NHS bands) at or above the relevant band rate typically meet the occupation's requirement. Individual eligibility depends on personal circumstances. These figures are public reference information, not advice or a verdict on this job.
Role description
Job summary
Shore Medical is seeking a Research GP to join our research team, working across our practice sites as required.
The post holder will work as a Sub-Investigator on clinical research studies, supporting the delivery of high-quality research in accordance with study protocols and Good Clinical Practice (GCP) guidelines. The role will involve the clinical assessment and ongoing care of research participants, including screening for eligibility, obtaining informed consent, undertaking clinical assessments and follow-up visits, and reviewing clinical and laboratory results to ensure participant safety and wellbeing.
We are looking for a GP with an interest in clinical research who is committed to delivering safe, high-quality patient care and maintaining the highest standards of GCP. The successful candidate will work closely with the Principal Investigator and wider research team, contributing to the successful delivery of clinical trials and ensuring participants are supported throughout their research journey.
Job Type: 12-month Fixed Term Contract commencing December 2026
Hours: 1 session per week (Thursday)
Main duties of the job
The Research GP will play an important role in the delivery of clinical trials across Shore Medical, working alongside the Principal Investigator and research team to ensure studies are conducted safely and effectively.
The role will involve clinical input throughout the research process, from assessing potential participants and confirming eligibility through to conducting study visits, reviewing investigations and monitoring participants during their involvement in a trial. The post holder will also identify and appropriately escalate any clinical concerns or significant results in accordance with study requirements.
This is an opportunity for a GP with an interest in research to contribute to the development of evidence-based healthcare while supporting patients to take part in research. The successful candidate will be organised, clinically confident and committed to maintaining high standards of participant care and GCP compliance.
About us
Shore Medical is a GP Super Partnership with 6 practices across Poole and Bournemouth. We aspire to offer exceptional care to our 58,000 patients and are innovative in our approach to developing new teams and pathways to ever improve how general practice is delivered.
We have a friendly and supportive team of more than 200 staff, with over 40 GPs, Pharmacists, Paramedics, Nurses, Mental Health specialists and our range of administrative staff. We have a great social side to our team with Summer and Christmas parties, running and paddle boarding groups as well as many other events throughout the year.
The Practices in the Partnership are:
- Lilliput Surgery
- Poole Road Medical Centre
- Wessex Road Surgery
- Heatherview Medical Centre
- Fernside Surgery
- Parkstone Tower Practice
We offer
- Competitive salary
- Friendly and supportive working environment
- Continuous CPD
- NHS Pension Scheme with Life Insurance
- Free parking at most of the sites
- Cycle to work scheme
- Refer a Friend scheme
- Summer & Christmas parties
Details
Date posted
26 August 2026
Pay scheme
Other
Salary
£11,800 a session
Contract
Fixed term
Duration
12 months
Working pattern
Part-time
Reference number
W0037-26-0026
Job locations
Poole Road Medical Centre
7 Poole Road
Bournemouth
BH2 5QR
United Kingdom
Last verified against our ingestion on 27 August 2026; sponsor register dataset 2026-08-25.